NCT06151080View on ClinicalTrials.gov

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

PHASE2RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma
Interventions
DRUG

Lenalidomide combined with G-CHOP (LO CHOP)

Lenalidomide combined with G-CHOP to treat newly diagnosed diffuse large B-cell lymphoma with follicular lymphoma (CDLBCL-FL)

Trial Locations (1)

361000

RECRUITING

Bing Xu, Xiamen

All Listed Sponsors
collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

Jiangxi Provincial Cancer Hospital

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

lead

The First Affiliated Hospital of Xiamen University

OTHER